Overview
Primary objectives:
- To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy.
- To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life.
Secondary objectives:
- To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens.
- Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.
Eligibility
Inclusion Criteria:
- women aged ≥18 and ≤ 55
- who underwent surgery for early stage breast cancer
- taking endocrine therapy for at least 3 months
- providing an informed consent and completing the study questionnaires.
Exclusion Criteria:
- withdrawal of the informed consent, at any time